Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults.

3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Eosinophilic esophagitis (EE) is a clinicopathologic syndrome comprising isolated eosinophilic inflammation of the esophagus, with symptoms of dysphagia, and possibly, reflux. It was initially described in children, and in recent years, there is a heightened awareness in adults. The etiology is not completely understood. The treatments include dietary manipulation, topical corticosteroids, systemic corticosteroids, Montelukast, and endoscopic dilation. In adults, there are no randomized trials demonstrating the efficacy of any particular treatment, and no prospective studies describing the natural history of the disease following treatment. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The American journal of gastroenterology Pubmed

3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults.

The American journal of gastroenterology , Volume 103 (9): -2184 – Dec 17, 2008

3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults.


Abstract

Eosinophilic esophagitis (EE) is a clinicopathologic syndrome comprising isolated eosinophilic inflammation of the esophagus, with symptoms of dysphagia, and possibly, reflux. It was initially described in children, and in recent years, there is a heightened awareness in adults. The etiology is not completely understood. The treatments include dietary manipulation, topical corticosteroids, systemic corticosteroids, Montelukast, and endoscopic dilation. In adults, there are no randomized trials demonstrating the efficacy of any particular treatment, and no prospective studies describing the natural history of the disease following treatment.

Loading next page...
 
/lp/pubmed/3-yr-follow-up-of-topical-corticosteroid-treatment-for-eosinophilic-tmbcFPww7Y

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0002-9270
DOI
10.1111/j.1572-0241.2008.01989.x
pmid
18637093

Abstract

Eosinophilic esophagitis (EE) is a clinicopathologic syndrome comprising isolated eosinophilic inflammation of the esophagus, with symptoms of dysphagia, and possibly, reflux. It was initially described in children, and in recent years, there is a heightened awareness in adults. The etiology is not completely understood. The treatments include dietary manipulation, topical corticosteroids, systemic corticosteroids, Montelukast, and endoscopic dilation. In adults, there are no randomized trials demonstrating the efficacy of any particular treatment, and no prospective studies describing the natural history of the disease following treatment.

Journal

The American journal of gastroenterologyPubmed

Published: Dec 17, 2008

References